BD Begins Clinical Trial for GalaFLEX LITE Scaffold in Breast Revision Surgery
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
Brian Pilcher, PhD, discusses Conexeu’s CXU platform and what 3D-printed extracellular matrix technology could mean for future reconstructive and aesthetic surgery.